Ozelo MC, Luciani M, Glosli H, Kavakli K, Samji N, Makris GC, Tueckmantel C, Enriquez MM, Oliveira LC, Gupta S, Arbesú MG, Davoli M, Chan AKC, Mancuso ME (2026)
Plain Language Summary on Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study
Eur J Haematol (in press)
DOI 10.1111/ejh.70078, PubMed 41531337

Ozelo MC, Luciani M, Glosli H, Kavakli K, Samji N, Makris GC, Tueckmantel C, Maas Enriquez M, Oliveira LC, Gupta S, Arbesú MG, Davoli M, Chan AKC, Mancuso ME (2026)
Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study
Eur J Haematol (in press)
DOI 10.1111/ejh.70059, PubMed 41486550

Greve-Isdahl M, Møller TKR, Bekkevold T, Baranowska-Hustad MN, Julin CH, Laake I, Berg AS, Aavitsland P, Knudsen PK, Aase A, Størdal K (2025)
Maternal and infant immunity against Bordetella pertussis, Norway, 2020 to 2023
Euro Surveill, 30 (50)
DOI 10.2807/1560-7917.ES.2025.30.50.2500450, PubMed 41414933